Dr. Frits Franssen
CIRO, Horn & MUMC, Maastricht
Niet-medicamenteuze
behandeling van COPD
Dr. Christel Haenebalcke
AZ Sint-Jan Brugge-Oostende AV, campus Brugge
‘
Pulmonary rehabilitation is a comprehensive intervention
based on a thorough patient assessment followed by
patient-tailored therapies, which include, but are not limited
to, exercise training, education and behavior change,
designed to improve the physical and emotional condition
of people with chronic respiratory disease and to promote
the long-term adherence of health-enhancing behaviors’
American Thoracic Society / European Respiratory
Society Statement on pulmonary rehabilitation 2013,
updated definition:
‘The purpose of pulmonary rehabilitation is to minimize
symptoms, maximize exercise performance, promote
autonomy, increase participation in everyday activities,
improve the overall quality of life, improve long-term
health-enhancing behavior, and provide tools to elicit behavior
change in physical activity and symptom management in
people with chronic respiratory disease’
American Thoracic Society / European Respiratory
Society Statement on pulmonary rehabilitation 2013,
purpose:
Frequency of most important outcomes of PR
Spruit et al., Eur Respir J 2014 A survey of 430 PR centres in 40 countries
‘
To address the complexity of chronic respiratory diseases,
pulmonary rehabilitation should be conducted by a dedicated,
interdisciplinary team including physicians and other
healthcare professionals, such as physiotherapist, respiratory
therapist, nurse, psychologist, exercise physiologist,
nutritionist, occupational therapist, and social worker. Each
program should be carefully constructed for the patient by the
pulmonary rehabilitation team after a thorough baseline and
ongoing assessment’
American Thoracic Society / European Respiratory
Society Statement on pulmonary rehabilitation 2013,
precautions:
Frequency of healthcare professionals in PR programmes
‘A pulmonary rehabilitation program is patient-centered and
therefore varies in components, complexity and duration
according to the clinical needs of the individual. Pulmonary
rehabilitation should be integrated throughout the clinical course
of a patient’s disease and modified to the complexity of disease
phenotypes including unique co-morbidities. Indeed, pulmonary
rehabilitation may be initiated either during a clinically stable
phase of the disease or during or directly following an acute
exacerbation of the disease or hospitalization’
American Thoracic Society / European Respiratory
Society Statement on pulmonary rehabilitation 2013,
positioning:
Spruit et al., Eur Respir J 2014
62 jarige dame met COPD, voorheen werkzaam in stoffeerderij
Voorgeschiedenis: fibromyalgie, migraine, depressie
In juni 2014 opgenomen met 1e
exacerbatie. Daarvoor niet
gediagnosticeerd. Kortademig bij inspanning, mMRC 2, chronisch hoesten, Zo’n 5 kilogram
afgevallen, veel spanningen
Medicatie: formoterol/budesonide 2dd, glycopyronium 1dd,
venlafaxine 1dd, sumatriptan zn
Rookstop juni 2014, 48 pakjaren
Verwijzing voor
longrevalidatie
FEV1, l (%) 1.1 (55%) FVC, l (%) 2.7 (103%) FEV1/FVC 0.43 FRC, l (%) 3.9 (152%) RV, l (%) 3.0 (166%) TLC, l (%) 5.6 (123%) DLCO, mmol/kg/min (%) 3.9 (49%) KCO, mmol/kg/min (%) 0.86 (56%) PaO2, kPa 10.2 ± 1.6 paCO2, kPa 5.2 ± 0.6
Assessment voorafgaand aan longrevalidatie
BMI, kg/m2 19.3 FFMI, kg/m2 13.5 T-score L2-L4 -1.5 T-score heup -2.2 6MWD 315 (52%) Saturatie 94 > 84% Wmax 48 (49%) VO2max 671 (57%) RER 1.11 HFmax 127 (80%) VEmax 31 (67%) BORG dyspnoe 0.5 - 9 BORG benen 1 - 6 Saturatie 94 > 88% CAT 23 HADS angst 11 HADS depressie 8
Fysiotherapeut: ‘Mevrouw staat
nu 7 minuten op de loopband en
de saturatie is 83%’. Mag ik haar
zuurstof geven?
☐
Verlagen van intensiteit
☐
Interval training
☐
Stoppen met training
☐
Zuurstof tijdens fysieke activiteiten
☐
Zuurstof tijdens loopband training
☐
Looptest met zuurstof
☐
Geen actie
☐
…
Prevalence of exercise-induced desaturation in COPD
6MWT is more sensitive than maximal incremental cycle testing!
20%
29%
51%
Poulain et al., Chest 2003
Adrianopoulos et al., Respir Physiol Neurobiol. 2014
Predicting exercise-induced desaturation in COPD
Prevalence: 39%
Patients (%F) 402 (43) Age, y 64.3 ± 8.0 BMI, kg/m2 25.6 ± 5.5 FFMI, kg/m2 17.2 ± 2.4 FEV1, l 1.4 ± 0.6 FEV1, % pred 51.9 ± 18.8 FRC, % pred 143.8 ± 34.1 DLCO, % pred 53.9 ± 19.7 PaO2, kPa 10.1 ± 1.6 paCO2, kPa 5.0 ± 0.6 6MWD, m 454 ± 103Is exertional desaturation predictive for outcomes in COPD?
Kim et al., Respiration 2013
33.8 ml/y 11.6 ml/y
COPD patients with exercise-induced desaturation have a greater rate of decline in FEV1 and change in health-related quality of life
1 Casanova et al., Chest 2008; 2 Takigawa et al., Respir Med 2007
In addition to resting paO2, oxygen desaturation predicts mortality
Exercise-induced desaturation predicts mortality in COPD
Sat > 90%
Sat < 90%
NVALT Richtlijn:
Zuurstofbehandeling thuis 2000
CBO Richtlijn:
‘Current evidence on ambulatory oxygen therapy reveals
improvements in dyspnoea post-exercise and in the dyspnoea and
fatigue domain of quality of life.’
‘However, evidence for the clinical utility and effectiveness in improving
mortality and exercise capacity was not evident.’
‘Methodologically rigorous RCTs with sufficient power are required to
investigate the role of ambulatory oxygen in the management of
COPD’
Training with supplemental oxygen during pulmonary
rehabilitation in patients with exercise hypoxaemia
Randomised trial Inclusion: COPD, normoxemia at rest (mean paO2 ± 10 kPa), desaturation below 90% at maximum
exercise
Exclusion: mPAP > 25 mmHg, neuromuscular or
cardiovascular disease
Compressed air: 4 l/min, during training sessions
Oxygen: 4 l/min, during training sessions
Programme: Multidisciplinary, inpatient PR, 5 days per week,
10 weeks
All patients were ex-smokers
Rooijackers et al., Eur Respir J 1997
*
*
*
Maximal load Cycling time 6MWD
Although acute oxygen supplementation improved exercise performance,
supplemental oxygen during training did not add to the effects or training on room air
Training with supplemental oxygen during pulmonary
Rooijackers et al., Eur Respir J 1997
Health status significantly improved after pulmonary rehabilitation, but there was no difference between the oxygen-trained and room air-trained group
Supplemental oxygen during pulmonary
rehabilitation: effects on health status
Garrod et al., Thorax 2000
Supplemental oxygen during pulmonary
rehabilitation in patients with exercise hypoxaemia
Randomised trial Inclusion: FEV1 < 40%, desaturation >4% and to < 90% during exercise testing
Compressed air: 4 l/min, during training sessions
Oxygen: 4 l/min, during training sessions
Programme: Outpatient PR, 3 times per week, 6 weeks
11 out of 25 patients used oxygen at home
Garrod et al., Thorax 2000
Supplemental oxygen during pulmonary
rehabilitation in patients with exercise hypoxaemia
Oxygen trained Air trained
Garrod et al., Thorax 2000
Supplemental oxygen during pulmonary
Training with supplemental oxygen during pulmonary
rehabilitation in patients with exercise hypoxaemia
Randomised trial Inclusion: COPD, resting saturation > 90%,
desaturation > 4% and below 90% during incremental shuttle walk test
Exclusion: LTOT, significant musculoskeletal,
cardiac, or cognitive problems
Control: no oxygen or sham during supervised
and unsupervised exercise
Oxygen: 2 l/min, during supervised and
unsupervised exercise
Programme: Supervised high-intensity walking and cycling,
2 days per week, 7 weeks; weekly education
Training with supplemental oxygen during pulmonary
rehabilitation in patients with exercise hypoxaemia
Ringbaek et al., Chron Respir Dis 2013
Ambulatory oxygen has no effect no effect on exercise tolerance,
health status, risk of exacerbation, hospitalization or drop-out
Dyer et al., Chron Respir Dis 2012
Single-blind randomised controlled trial
Inclusion: normoxemic at rest, desaturation >4%
and to <90% during exercise and >10%
improvement with oxygen during endurance shuttle walk test
Room Air: during all activities that induced dyspnea
Oxygen: during all activities that induced dyspnea
Patient selection: the key to success?
Programme: Outpatient PR, 2 times per week, 6-7 weeks
All patients with oxygen naive
Endurance shuttle walk test
Health status, emotion and function
Dyer et al., Chron Respir Dis 2012
Oxygen therapy during pulmonary rehabilitation in
selected patients
Ambulatory oxygen during a 6- to 7-week PR programme
Responders and non-responders to oxygen therapy
Heraud et al., Respir Med 2008
N = 25, FEV1 52%, exercise-induced
desaturation
Endurance cycle test with room air and
oxygen Responders: >10% increase
Heraud et al., Respir Med 2008
Importance
of patient
selection?
1) Exercise-induced desaturation occurs in 30-50% of patients with moderate to severe COPD
2) Exercise-induced desaturation is associated with worse patient-related outcomes, including increased mortality risk 3) There is no evidence to support the use of ambulatory oxygen
in COPD patients with exercise-induced desaturation 4) In general, oxygen therapy does not add to the effects of
pulmonary rehabilitation
5) Possibly, determining acute response to oxygen supplementation will predict long-term benefit
Conclusions part I:
Dietiste: ‘Mevrouw is in de
eerste weken van de revalidatie
2 kilogram afgevallen. Wat nu?
☐
Revalidatie stoppen
☐
Verlagen van intensiteit van training
☐
Krachttraining
☐
Bijvoeding
☐
Anabole steroiden
☐
Analyse lichaamssamenstelling
☐
Geen actie
☐
…
Ferreira et al., Chest 1998
Changes in body composition during
pulmonary rehabilitation
van den Borst et al., Thorax 2011
COPD: a wasting disease?
Change in body weight Change in lean mass
Decline in body weight and lean mass is comparable in subjects with OLD, smoking and non-smoking controls
Vanfleteren et al., Am J Respir Crit Care Med 2013
Clustering of objectively identified comorbidities in COPD
Body composition is an important discriminating factor in
unbiased clustering of COPD
Metabolic phenotype
Bronchial wall thickening Atherosclerosis
High fat mass
ERS Taskforce ‘Nutrition in COPD’, Eur Respir J 2014
Cachectic phenotype
Emphysema
Low muscle mass
Osteoporosis
Low fat mass Underweight
Fibre type shift I > II
Classical COPD phenotypes revisited
ERS Taskforce ‘Nutrition in COPD’, Eur Respir J 2014
Nutritional supplementation for stable COPD
Aims:
1)
To assess the effect of nutritional support for more than two weeks
on body composition, muscle function, exercise tolerance and
health status in stable COPD
2)
To identify treatment regimens and patient populations that
demonstrate the greatests benefits
17 studies, 632 randomised participants
5 studies had nutritional supplementation combined with exercise
Change in body weight
Nutritional supplementation for stable COPD
Ferreira et al., Cochrane Database Syst Rev 2012 Change in fat-free mass
Change in functional exercise capacity
Nutritional supplementation should be considered in the management of undernourished COPD patients
Nutritional supplementation for stable COPD
1) Body composition is an important discriminating factor in the clustering of COPD patients
2) New longitudinal studies challenge the concept of COPD as a wasting disease
3) Updated meta-analysis showed that nutritional
supplementation promotes weight and fat-free mass gain, exercise tolerance and health status, mainly in underweight patients
4) In the next years, focus will shift towards overweight and obesity and cardiometabolic risk